- Report
- January 2026
- 150 Pages
Global
From €5307EUR$5,950USD£4,552GBP
- Report
- November 2025
- 120 Pages
Global
From €5307EUR$5,950USD£4,552GBP
- Report
- November 2025
- 120 Pages
Global
From €5307EUR$5,950USD£4,552GBP
- Report
- October 2025
- 180 Pages
Global
From €5307EUR$5,950USD£4,552GBP
- Report
- October 2025
- 150 Pages
Global
From €5307EUR$5,950USD£4,552GBP
- Report
- October 2025
- 120 Pages
Global
From €5307EUR$5,950USD£4,552GBP
- Report
- June 2026
- 139 Pages
Global
From €2675EUR$2,999USD£2,294GBP
€3567EUR$3,999USD£3,059GBP
- Report
- May 2026
- 145 Pages
Global
From €2675EUR$2,999USD£2,294GBP
€3567EUR$3,999USD£3,059GBP
- Report
- May 2026
- 147 Pages
Global
From €2675EUR$2,999USD£2,294GBP
€3567EUR$3,999USD£3,059GBP
- Report
- April 2026
- 147 Pages
Global
From €2675EUR$2,999USD£2,294GBP
€3567EUR$3,999USD£3,059GBP
- Report
- April 2026
- 140 Pages
Global
From €2675EUR$2,999USD£2,294GBP
€3567EUR$3,999USD£3,059GBP
- Report
- April 2026
- 146 Pages
Global
From €2675EUR$2,999USD£2,294GBP
€3567EUR$3,999USD£3,059GBP
- Report
- April 2026
- 143 Pages
Global
From €2675EUR$2,999USD£2,294GBP
€3567EUR$3,999USD£3,059GBP
- Report
- April 2026
- 140 Pages
Global
From €2675EUR$2,999USD£2,294GBP
€3567EUR$3,999USD£3,059GBP
- Report
- April 2026
- 137 Pages
Global
From €2675EUR$2,999USD£2,294GBP
€3567EUR$3,999USD£3,059GBP
- Report
- March 2026
- 145 Pages
Global
From €2675EUR$2,999USD£2,294GBP
€3567EUR$3,999USD£3,059GBP
- Report
- February 2026
- 144 Pages
Global
From €2675EUR$2,999USD£2,294GBP
€3567EUR$3,999USD£3,059GBP
- Report
- January 2026
- 286 Pages
Global
From €2230EUR$2,500USD£1,913GBP
- Report
- January 2026
- 291 Pages
Global
From €2230EUR$2,500USD£1,913GBP
- Report
- September 2026
- 200 Pages
Global
From €5218EUR$5,850USD£4,475GBP

The RNA market is a subset of the genomics market that focuses on the study of ribonucleic acid (RNA). RNA is a molecule that plays a key role in the regulation of gene expression and is involved in many cellular processes. It is used in a variety of applications, including diagnostics, therapeutics, and research.
The RNA market is expected to grow at a steady rate due to the increasing demand for RNA-based products and services. This growth is driven by advances in technology, such as next-generation sequencing, which has enabled the development of more accurate and cost-effective RNA-based products. Additionally, the increasing prevalence of chronic diseases and the need for personalized medicine are expected to drive the growth of the RNA market.
Companies in the RNA market include Illumina, Thermo Fisher Scientific, Qiagen, Agilent Technologies, Bio-Rad Laboratories, and F. Hoffmann-La Roche. Show Less Read more